What do expensive drugs have in common? A new study breaks it down. – Boston Business Journal

Posted: Published on May 24th, 2017

This post was added by Dr Simmons

What do expensive drugs have in common? A new study breaks it down.
Boston Business Journal
According to the study, four of the drugs in the top tier are sold by local companies: Duchenne muscular dystrophy treatment Exondys 51, made by Sarepta Therapeutics (Nasdaq: SRPT); spinal muscular atrophy drug Spinraza, made by Biogen (Nasdaq: BIIB); ...

Read more here:
What do expensive drugs have in common? A new study breaks it down. - Boston Business Journal

Related Posts
This entry was posted in Muscular Dystrophy Treatment. Bookmark the permalink.

Comments are closed.